Phase 3 Multicenter Randomized Double Blind Placebo Controlled Study With Antibacterial Prophylaxis in Azacitidine Treated MDS Patients
Clinical trial NCT02981615 · COMPLETED
Trial details
- NCT number
- NCT02981615
- Sponsor
- Sheba Medical Center
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-01
- Primary completion
- 2022-07-30
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.